LIPT - Liraglutide in Polycystic Ovary Syndrome
Phase 4
Completed
- Conditions
- Polycystic Ovary SyndromeCardiovascular Disease
- Interventions
- Drug: placeboDrug: Liraglutide for 26 weeks
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- Jens Faber
- Target Recruit Count
- 72
- Registration Number
- NCT02073929
- Locations
- 🇩🇰
Dept. of Medicine and Dept. of Gyn-Obs, Herlev Hospital, Herlev, Denmark
🇩🇰Dept. of Medicine and Dept. of Obstetrics and Gynaecology, Herlev Hospital, Herlev, Denmark
🇩🇰Herlev Hospital, Dept of Gynecology, Herlev, Denmark
Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)
- First Posted Date
- 2011-11-29
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Jens Faber
- Target Recruit Count
- 21
- Registration Number
- NCT01481402
- Locations
- 🇩🇰
Herlev Hospital, Dept. of Endocrinology, Herlev, Denmark
© Copyright 2025. All Rights Reserved by MedPath